GSK3B and Insulin resistance: Furthermore, we and others have reported that beyond its implication in insulin resistance in target tissues, GSK3β acts as a negative regulator of β-cell growth and function, thus further implicating this enzyme in the relative insulin deficiency associated with T2D (43–46).